Literature DB >> 29265685

Prevalence of post-micturition dribble in Japanese men and its relationship with benign prostatic hyperplasia/lower urinary tract symptoms.

Ko Kobayashi1, Fumimasa Fukuta1, Naoya Masumori1.   

Abstract

OBJECTIVE: Post-micturition dribble (PMD) is one of the post-micturition lower urinary tract symptoms (LUTS). Although there have been many studies of LUTS in Japanese men, PMD is not completely understood in the Japanese population. In the present study, we investigated the prevalence and bother of PMD in Japanese men.
METHODS: From 2007 to 2008, a cross-sectional community-based study on LUTS was conducted in Japanese men aged 40-79 years in Shimamaki-mura, Hokkaido, Japan. The prevalence and bother of PMD were investigated using a validated questionnaire, and prostate volume (PV) and the peak flow rate (Qmax ) were measured.
RESULTS: The prevalence of PMD in men aged their 40s, 50s, 60s, and 70s was 13.6%, 39.0%, 44.2%, and 41.2%, respectively. PMD was not rare compared with other LUTS. The degree and bother of PMD were statistically correlated (r = 0.558, P < .001), suggesting that the presence of PMD impairs quality of life. There was no significant relationship between the prevalence of PMD and PV or Qmax .
CONCLUSIONS: PMD is not rare compared with other LUTS. The presence of PMD impairs quality of life.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  aging male; lower urinary tract symptoms; post-micturition dribble

Mesh:

Year:  2017        PMID: 29265685     DOI: 10.1111/luts.12210

Source DB:  PubMed          Journal:  Low Urin Tract Symptoms        ISSN: 1757-5664            Impact factor:   1.592


  1 in total

1.  The pressure flow study investigation of pathophysiology of post-micturition dribble in male patients.

Authors:  Mamoru Hashimoto; Nobutaka Shimizu; Saizo Fujimoto; Ken Kuwahara; Mitsuhisa Nishimoto; Shogo Adomi; Eri Banno; Takafumi Minami; Kazutoshi Fujita; Kazuhiro Yoshimura; Akihide Hirayama; Hirotsugu Uemura
Journal:  Int Urol Nephrol       Date:  2022-09-20       Impact factor: 2.266

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.